These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 16556772)
1. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design. El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772 [TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer. Degrève B; Andrei G; Izquierdo M; Piette J; Morin K; Knaus EE; Wiebe LI; Basrah I; Walker RT; De Clercq E; Balzarini J Gene Ther; 1997 Oct; 4(10):1107-14. PubMed ID: 9415318 [TBL] [Abstract][Full Text] [Related]
3. Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase. Balzarini J; Sienaert R; Liekens S; Van Kuilenburg A; Carangio A; Esnouf R; De Clercq E; McGuigan C Mol Pharmacol; 2002 May; 61(5):1140-5. PubMed ID: 11961132 [TBL] [Abstract][Full Text] [Related]
4. Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells. Grignet-Debrus C; Calberg-Bacq CM Gene Ther; 1997 Jun; 4(6):560-9. PubMed ID: 9231072 [TBL] [Abstract][Full Text] [Related]
5. Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity. Balzarini J; Van Daele I; Negri A; Solaroli N; Karlsson A; Liekens S; Gago F; Van Calenbergh S Mol Pharmacol; 2009 May; 75(5):1127-36. PubMed ID: 19233899 [TBL] [Abstract][Full Text] [Related]
6. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase. Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847 [TBL] [Abstract][Full Text] [Related]
7. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication. Balzarini J; McGuigan C J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000 [TBL] [Abstract][Full Text] [Related]
8. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains. Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985 [TBL] [Abstract][Full Text] [Related]
9. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents. Yang L; Mo X; Yang H; Dai H; Tan F J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898 [TBL] [Abstract][Full Text] [Related]
10. Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1. De Winter H; Herdewijn P J Med Chem; 1996 Nov; 39(24):4727-37. PubMed ID: 8941385 [TBL] [Abstract][Full Text] [Related]
11. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells. Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459 [TBL] [Abstract][Full Text] [Related]
12. Identification of factors important for the success of suicide gene therapy after a comparative study of Varicella zoster and Herpes simplex viral thymidine kinases efficacy on breast cancer cells. Grignet-Debrus C; Noël A; Foidart JM; Calberg-Bacq CM Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):37-48. PubMed ID: 16171563 [TBL] [Abstract][Full Text] [Related]
13. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus. Suzuki M; Okuda T; Shiraki K Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734 [TBL] [Abstract][Full Text] [Related]
15. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. Sienaert R; Andrei G; Snoeck R; De Clercq E; McGuigan C; Balzarini J Biochem Biophys Res Commun; 2004 Mar; 315(4):877-83. PubMed ID: 14985094 [TBL] [Abstract][Full Text] [Related]